Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novartis Ag ADR
(NY:
NVS
)
115.20
+0.50 (+0.44%)
Streaming Delayed Price
Updated: 9:43 AM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novartis Ag ADR
< Previous
1
2
3
4
5
6
7
8
9
...
40
41
Next >
The 3 Most Undervalued Pharma Stocks to Buy in July 2024
July 12, 2024
Pharma stocks can be great investments during times of growth and recession, and are made even better if the stock is undervalued.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Novartis Stock Generating Improved Relative Strength
July 08, 2024
Top and bottom line growth moved higher in Novartis' most recent quarter. EPS rose 17% to $1.80. Revenue increased 10% to $12.1 billion.
Via
Investor's Business Daily
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
July 05, 2024
UK regulators reprimand Novo Nordisk for failing to disclose nearly $10 million in fees and expenses. The PMCPA cites breaches in financial categorization and highlights similar issues with Novartis...
Via
Benzinga
What The Quest For New Cholesterol Treatments Means For Novartis, Merck — And Patients
July 05, 2024
A number of companies are working on new drugs for high lipids, including cholesterol and triglycerides.
Via
Investor's Business Daily
Upcoming Stock Spinoffs: Should You Pounce or Pass?
July 04, 2024
Stock spinoffs are a unique opportunity to pick up unloved, unwanted businesses but patience is often needed before buying in.
Via
InvestorPlace
Exploring NYSE:NVS's dividend characteristics.
June 21, 2024
Why NOVARTIS AG-SPONSORED ADR (NYSE:NVS) qualifies as a good dividend investing stock.
Via
Chartmill
Balancing Dividends and Fundamentals: The Case of NYSE:NVS.
May 30, 2024
Is NOVARTIS AG-SPONSORED ADR (NYSE:NVS) suited for dividend investing?
Via
Chartmill
Mississippi Judge Upholds State Law Mandating Drug Discounts for Low-Income Patients
July 02, 2024
A Mississippi judge upheld a state law requiring drugmakers to offer discounts on medications through third-party pharmacies for low-income populations, rejecting lawsuits from PhRMA and Novartis.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Superlab Suisse opens state-of-the-art facility in Basel, fostering new spaces for scientific breakthroughs
June 25, 2024
With this new facility, Superlab Suisse becomes the largest private lab space in Switzerland.
Via
News Direct
Novartis Stock Just Below Innovative Drugmaker's All-Time High; Gets Key Rating Upgrade
June 25, 2024
Novartis stock is in a buy range after moving past a 103.55 entry in a cup with handle. The buy range extends to 5% above the initial entry.
Via
Investor's Business Daily
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line
June 21, 2024
Nestle's new Vital Pursuit brand targets individuals on weight-loss drugs without mentioning medications on packaging, addressing regulatory concerns and focusing on marketing through social media.
Via
Benzinga
German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount
June 20, 2024
Evotec consults defense advisers following a significant share price decline, raising concerns about a potential takeover.
Via
Benzinga
What's Going On With Neurological Disease Focused Trevena On Thursday?
June 20, 2024
Trevena shares dropped 33.7% to $0.23 with a session volume of 23.65 million. Notably, TRV045 did not cause S1P1R desensitization or protein reduction, unlike fingolimod.
Via
Benzinga
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
June 17, 2024
With biotech stocks enjoying a permanently relevant narrative, investors should focus on these compelling opportunities.
Via
InvestorPlace
3 Crazy Good Stocks to Buy With $500 Right Now
June 12, 2024
For investors with only a little money to spare, these three supercharged stocks represent an outrageous opportunity for future growth.
Via
InvestorPlace
Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations
June 06, 2024
Italy's antitrust authority is investigating Novartis and Roche's Genentech for allegedly delaying the Italian market launch of Byooviz, a Samsung Bioepis biosimilar of Lucentis.
Via
Benzinga
Leigh Burgess, CEO & Founder Bold Industries Group, Announces Pre-Sale of New Book: Be BOLD Today
June 04, 2024
Via
Get News
The 3 Most Undervalued Healthcare Stocks to Buy in June 2024
June 04, 2024
Seeking discounts in relevant places makes sense and there are few arenas more compelling than undervalued healthcare stocks.
Via
InvestorPlace
Novartis Sues to Block Maryland's New Drug Discount Law
May 31, 2024
Novartis has filed a lawsuit to block a Maryland law requiring drugmakers to offer discounts on drugs through third-party pharmacies contracting with hospitals and clinics.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Novartis' Oral Drug For Chronic Skin Disease Candidate Shows Efficacy, Long-term Safety
May 31, 2024
Novartis reveals Phase 3 data confirming remibrutinib's long-term efficacy and safety for chronic spontaneous urticaria, showing significant symptom improvement and a favorable safety profile up to...
Via
Benzinga
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
May 24, 2024
Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications.
Via
Benzinga
Topics
Data Breach
Exposures
Information Security
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
May 16, 2024
On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France,...
Via
Benzinga
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
May 16, 2024
AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
May 16, 2024
The FTC is putting these three drug stocks at risk by trying to strip their therapies of protection from generics.
Via
InvestorPlace
Topics
Intellectual Property
Exposures
Intellectual Property
3 Magnificent Stocks That Are Passive Income Machines
May 14, 2024
These three companies have track records that should please investors.
Via
The Motley Fool
The 3 Best Mutual Funds to Buy in May 2024
May 11, 2024
Consider the best mutual funds to buy for high returns and low fees. They each have unique strategies meant to maximize returns on capital.
Via
InvestorPlace
MacroGenics Gets Downgraded Following Disappointing Prostate Cancer Trial Results: 'We Were Surprised By Reported Deaths'
May 10, 2024
Despite MacroGenics' clinical activity, unexpected adverse events raise concerns. Analysts adjust ratings and price targets.
Via
Benzinga
3 Biotech Stocks to Sell in May Before They Crash & Burn
May 10, 2024
Discover essential insights on biotech stocks to sell in May to navigate market volatility and safeguard your investment portfolio.
Via
InvestorPlace
Google DeepMind Develops Latest AI Model To Aid Scientists In Fighting Disease
May 08, 2024
Google DeepMind reveals its AlphaFold 3, which specializes in molecular predictions for proteins, DNA, RNA, and drug molecules.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Axmed raises $2 million to transform access to critical medicines in low and middle income countries
May 08, 2024
Axmed’s B2B marketplace aggregates demand for critical medicines in underserved regions to improve the availability, affordability, and distribution of life-saving medicine.
Via
News Direct
< Previous
1
2
3
4
5
6
7
8
9
...
40
41
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.